SCHEMBL657068

SCHEMBL657068

O=C(O)CC(CC(=O)OC(=O)CC(CC(=O)O)c1cccc2ccccc12)c1cccc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 2/20 0.54
HTT P42858 1/20 0.54
ALDH1A1 P00352 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ACP3 P15309 3/20 0.41
CYP1A2 P05177 2/20 0.41
CASP1 P29466 1/20 0.41
GABBR2 O75899 1/20 0.39
GABBR1 Q9UBS5 1/20 0.39
NR4A1 P22736 1/20 0.39
NR4A2 P43354 1/20 0.39
NR4A3 Q92570 1/20 0.39
MTNR1A P48039 3/20 0.38
MTNR1B P49286 3/20 0.38
HTR2C P28335 2/20 0.38
PTGER4 P35408 1/20 0.38
METAP2 P50579 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL656946 0.91 HPGD (0.62) HPGDCYP2C9CYP2C19HTTALDH1A1
SCHEMBL5280121 0.88 CYP2C19 (0.51) HPGDCYP2C9CYP2C19HTTALDH1A1
SCHEMBL5280903 0.88 CYP2C19 (0.51) HPGDCYP2C9CYP2C19HTTALDH1A1
SCHEMBL14582250 0.83 HTT (0.55) HPGDCYP2C9CYP2C19HTTALDH1A1
SCHEMBL11040097 0.81 GABBR2 (0.57) HPGDCYP2C9CYP2C19HTTALDH1A1
SCHEMBL3814689 0.81 CYP2C9 (0.56) HPGDCYP2C9CYP2C19HTTALDH1A1
SCHEMBL9807303 0.79 HPGD (0.54) HPGDCYP2C9CYP2C19HTTALDH1A1
SCHEMBL657210 0.78 GABBR2 (0.41) CYP2C9CYP2C19HTTCYP1A2GABBR2
SCHEMBL657343 0.78 CTSA (0.42) HTTGABBR2GABBR1
SCHEMBL18151385 0.77 POLB (0.63) HPGDHTTGABBR2GABBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB HPGD 4359/4885CYP2C9 4696/4885CYP2C19 4532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.